Evidence map›Paper›PMID 25593309›Full record

ArticleGenes & development2015

Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.

Fade Gong, Li-Ya Chiu, Ben Cox, François Aymard, Thomas Clouaire, Justin W Leung, Michael Cammarata, Mercedes Perez, Poonam Agarwal, Jennifer S Brodbelt and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 162 papers.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 243 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Nucleoporins cooperate with Polycomb silencers to promote transcriptional repression and repair at DNA double-strand breaks.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Fade GongInstitute for Cellular and Molecular Biology, Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712, USA;
Li-Ya ChiuInstitute for Cellular and Molecular Biology, Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712, USA;
Ben CoxInstitute for Cellular and Molecular Biology, Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712, USA;
François AymardLaboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération, Université de Toulouse/Université Paul Sabatier, 31062 Toulouse, France. Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération, Centre National de la Recherche Scientifique (CNRS), 31062 Toulouse, France.
Thomas ClouaireLaboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération, Université de Toulouse/Université Paul Sabatier, 31062 Toulouse, France. Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération, Centre National de la Recherche Scientifique (CNRS), 31062 Toulouse, France.
Justin W LeungInstitute for Cellular and Molecular Biology, Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712, USA;
Michael CammarataDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, USA.
Mercedes PerezInstitute for Cellular and Molecular Biology, Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712, USA;
Poonam AgarwalInstitute for Cellular and Molecular Biology, Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712, USA;
Jennifer S BrodbeltDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, USA.
Gaëlle LegubeLaboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération, Université de Toulouse/Université Paul Sabatier, 31062 Toulouse, France. Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération, Centre National de la Recherche Scientifique (CNRS), 31062 Toulouse, France.
Kyle M MillerInstitute for Cellular and Molecular Biology, Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712, USA; kyle.miller@austin.utexas.edu.
The University of Texas at Austin · USInstitut de Biologie Moléculaire et Cellulaire · FR

Funding

UV Photodissociation for Acidic and Basic Proteome CharacterizationR21GM099028 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI BRODBELT, JENNIFER S. · 2011 to 2012
$384k
NIGMS NIH HHS R21_GM099028
6 · The paper itself

Abstract

How chromatin shapes pathways that promote genome-epigenome integrity in response to DNA damage is an issue of crucial importance. We report that human bromodomain (BRD)-containing proteins, the primary "readers" of acetylated chromatin, are vital for the DNA damage response (DDR). We discovered that more than one-third of all human BRD proteins change localization in response to DNA damage. We identified ZMYND8 (zinc finger and MYND [myeloid, Nervy, and DEAF-1] domain containing 8) as a novel DDR factor that recruits the nucleosome remodeling and histone deacetylation (NuRD) complex to damaged chromatin. Our data define a transcription-associated DDR pathway mediated by ZMYND8 and the NuRD complex that targets DNA damage, including when it occurs within transcriptionally active chromatin, to repress transcription and promote repair by homologous recombination. Thus, our data identify human BRD proteins as key chromatin modulators of the DDR and provide novel insights into how DNA damage within actively transcribed regions requires chromatin-binding proteins to orchestrate the appropriate response in concordance with the damage-associated chromatin context.

Indexed as

DNA DamageAutoantigensCell Line, TumorChromatinGene Expression RegulationGene SilencingHomologous RecombinationHumansMi-2 Nucleosome Remodeling and Deacetylase ComplexProtein BindingProtein TransportReceptors, Cell SurfaceReceptors for Activated C KinaseTumor Suppressor ProteinsAutoantigensCHD4 protein, humanChromatinMi-2 Nucleosome Remodeling and Deacetylase ComplexReceptors, Cell SurfaceReceptors for Activated C KinaseTumor Suppressor ProteinsZMYND8 protein, humanbromodomainchromatinDNA damagehistone acetylationZMYND8

Identifiers

PMID25593309
PMCPMC4298138
OpenAlexW2169001246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.